Arizona State Retirement System decreased its position in shares of Agilent Technologies Inc (NYSE:A) by 0.6% in the 3rd quarter, HoldingsChannel reports. The fund owned 162,058 shares of the medical research company’s stock after selling 1,001 shares during the period. Arizona State Retirement System’s holdings in Agilent Technologies were worth $11,432,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. grew its holdings in Agilent Technologies by 75.9% during the second quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock worth $110,000 after buying an additional 773 shares in the last quarter. Moneta Group Investment Advisors LLC grew its holdings in Agilent Technologies by 391.7% during the second quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock worth $158,000 after buying an additional 4,798 shares in the last quarter. TRUE Private Wealth Advisors bought a new stake in Agilent Technologies during the third quarter worth $181,000. Bray Capital Advisors grew its holdings in Agilent Technologies by 12,000.0% during the second quarter. Bray Capital Advisors now owns 3,025 shares of the medical research company’s stock worth $187,000 after buying an additional 3,000 shares in the last quarter. Finally, AMG National Trust Bank bought a new stake in Agilent Technologies during the third quarter worth $212,000.
In other news, Director Heidi Fields sold 5,482 shares of the company’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total transaction of $371,295.86. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Paul N. Clark sold 2,876 shares of the company’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $68.60, for a total value of $197,293.60. The disclosure for this sale can be found here.
Shares of NYSE:A opened at $65.22 on Friday. The firm has a market capitalization of $20.29 billion, a price-to-earnings ratio of 24.01, a price-to-earnings-growth ratio of 2.18 and a beta of 1.32. The company has a quick ratio of 3.00, a current ratio of 3.62 and a debt-to-equity ratio of 0.39. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $75.00.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.04. The firm had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a return on equity of 18.61% and a net margin of 6.20%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 EPS. On average, equities analysts forecast that Agilent Technologies Inc will post 2.71 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 24th. Stockholders of record on Tuesday, October 2nd were given a dividend of $0.149 per share. The ex-dividend date was Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.91%. Agilent Technologies’s dividend payout ratio is presently 25.42%.
A number of research analysts have issued reports on the company. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, July 25th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a research note on Tuesday, August 7th. Morgan Stanley upped their price objective on Agilent Technologies from $83.00 to $84.00 and gave the company an “overweight” rating in a research note on Wednesday, August 15th. Deutsche Bank upped their price objective on Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, August 15th. Finally, Goldman Sachs Group upgraded Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a research note on Monday, September 17th. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $77.44.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: Penny Stocks
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.